BOEHRINGER INGELHEIM LIMITED
Company Information
- Company Number
- 00711858
- Registered Address
- Ellesfield Avenue, Bracknell, Berkshire, RG12 8YS
- Status
- Active
- Employee Count
- 348.0
- Turnover
- 314669000.0
- EBITDA
- 10164000.0
Additional Details
- Company Type
- Private limited Company
- Incorporated On
- 1 January 1962
- Nature of Business
- 21100 - Manufacture of basic pharmaceutical products
- Industries
- Life Sciences And Medical Technology
- Region
- South East
Company Location
Loading map...
Financial Metrics
Time to Pay
Payment Timeline
Payment Features
Payment Time Trends
Payment Distribution Trends
Performance Reports History
| Reporting Period | Filing Date | Average Time to Pay (days) | Paid within 30 days | Paid 31-60 days | Paid after 60 days | Not Paid within Terms |
|---|---|---|---|---|---|---|
| 01 Jul 2023 - 31 Dec 2023 | 31 Jan 2024 | 18 | 83% | 16% | 1% | 23% |
| 01 Jan 2023 - 30 Jun 2023 | 22 Sept 2023 | 21 | 80% | 20% | 0% | 39% |
| 01 Jul 2022 - 31 Dec 2022 | 31 Jan 2023 | 24 | 76% | 23% | 1% | 22% |
| 01 Jan 2022 - 30 Jun 2022 | 14 Jul 2022 | 24 | 77% | 22% | 1% | 20% |
| 01 Jul 2021 - 31 Dec 2021 | 28 Jan 2022 | 24 | 77% | 22% | 1% | 20% |
| 01 Jan 2021 - 30 Jun 2021 | 28 Jul 2021 | 24 | 77% | 21% | 2% | 35% |
| 01 Jul 2020 - 31 Dec 2020 | 28 Jan 2021 | 28 | 69% | 29% | 2% | 28% |
| 01 Jan 2020 - 30 Jun 2020 | 30 Jul 2020 | 34 | 54% | 43% | 3% | 28% |
| 01 Jul 2019 - 31 Dec 2019 | 30 Jan 2020 | 38 | 54% | 41% | 5% | 32% |
| 01 Jan 2019 - 30 Jun 2019 | 19 Jul 2019 | 31 | 62% | 32% | 6% | 37% |
| 01 Jul 2018 - 31 Dec 2018 | 31 Jan 2019 | 41 | 26% | 52% | 22% | 31% |
| 01 Jan 2018 - 30 Jun 2018 | 29 Jul 2018 | 40 | 35% | 48% | 17% | 37% |
Company Summary
Boehringer Ingelheim Limited is a multinational pharmaceutical company that operates in the UK
It was founded in 1885 and is now headquartered in Bracknell, Berkshire
The company is committed to sustainability and has implemented various initiatives to reduce its environmental impact and promote social responsibility
The company's sustainability program focuses on five key areas: reducing carbon emissions, conserving natural resources, promoting animal welfare, supporting local communities, and ensuring ethical business practices
Boehringer Ingelheim Limited has also set ambitious targets to become carbon-neutral by 2025 and to achieve zero waste to landfill by 2022
As a pharmaceutical company, Boehringer Ingelheim Limited offers a wide range of products and services in the areas of human pharmaceuticals, animal health, and biopharmaceuticals
Its products include treatments for respiratory diseases, cardiovascular diseases, and diabetes, as well as vaccines for livestock and pets
The key people at Boehringer Ingelheim Limited include Hubertus von Baumbach, the Chairman of the Board of Managing Directors, and Michael Schmelmer, the Chief Financial Officer
The company has over 10,000 employees in the UK and is also committed to providing a safe and inclusive workplace for its employees
For more information about Boehringer Ingelheim Limited and its sustainability efforts, customers can visit their website at www.boehringer-ingelheim.co.uk
The registered office address is Boehringer Ingelheim Limited, Ellesfield Avenue, Bracknell, Berkshire, RG12 8YS, UK
Company Review
Trend Analysis
The data shows that BOEHRINGER INGELHEIM LIMITED has been consistently improving its average time to pay invoices over the past three periods. From 2018 to 2023, the average time to pay has decreased from 40 days to 18 days. This indicates that the company is making efforts to pay its suppliers more promptly.
Volatility Analysis
The data also shows that the company has experienced a decrease in the percentage of invoices paid later than 60 days over the past three periods. This indicates that the company has become more consistent in paying its invoices on time.
Summary Analysis
From 2018 to 2023, BOEHRINGER INGELHEIM LIMITED has consistently improved its average time to pay invoices. The percentage of invoices paid within 30 days has increased from 35% to 83%, and the percentage of invoices paid later than 60 days has decreased from 17% to 1%. This indicates that the company has become more efficient in paying its invoices on time.
Invoice Payment Practices
This information is as reported by the business, and responses are in their own words.
Payment Terms
Standard payment terms
Standard payment terms are 60 days. Details are on the Company website https://www.boehringer-ingelheim.com/uk/bipdf/potermsandconditionsv12dec2018pdf
Were there any changes to the standard payment terms in the reporting period?
No
Any other information about payment terms
N/A
Maximum contractual payment period agreed
60
Dispute Resolution Process
Boehringer Ingelheim has an Accounts Payable shared service centre based in Europe which can be contacted by email or by using a local UK telephone number.
Other Payment Information
Has this business signed up to a code of conduct or standards on payment practices?
For example, signatories to The Prompt Payment Code must commit to paying 95% of their invoices within 60 days.
❌
Does this business offer e-invoicing in relation to qualifying contracts?
This is where suppliers can electronically submit and track invoices. It's not just allowing suppliers to email them an invoice.
❌
Does this business offer supply chain finance?
This is where a supplier who has submitted an invoice can be paid by a third-party finance provider earlier than the agreed payment date. The business would then pay the finance provider the invoiced sum.
❌
Under its payment practices and policies, can this business deduct sums from payments under qualifying contracts as a charge for remaining on a supplier list?
❌
During the reporting period, did the business deduct sums from payments as a charge for remaining on a supplier list?
No information available
